Testing effectiveness (Phase 2)Ended earlyNCT02525263
What this trial is testing
Autologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease (CKD)
Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes
Prokidney 1